Biological and In Silico Evaluation of Novel Methoxyphenol–1,2,3‐Triazole Hybrids as Multifunctional Anti‐Alzheimer's and Anticancer Agents
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Sultan Onur und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Sciences, Kahramanmaraş Sütçü İmam University, Kahramanmaras, Turkey. Hauptthemen laut MEDLINE: Triazoles, Antineoplastic Agents, Cholinesterase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kahramanmaraş Sütçü İmam University.
Themen: Demenz
Abstract (Originalsprache)
The development of multifunctional small molecules capable of simultaneously modulating multiple pathological pathways represents a rational strategy in medicinal chemistry for complex disorders such as Alzheimer's disease (AD) and cancer. Herein, a novel series of methoxyphenol‐based 1,2,3‐triazole hybrids ( 5a–h ) was designed and synthesized via Cu(I)‐catalyzed azide–alkyne cycloaddition (CuAAC). All derivatives were fully characterized by FT‐IR, 1 H/ 13 C NMR spectroscopy, and elemental analysis. Biological evaluation encompassed in vitro antioxidant screening (DPPH•, ABTS• + , and CUPRAC), acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition (modified Ellman method), and antiproliferative activity against the PC3 prostate cancer cell line using HDF‐1 healthy fibroblasts as a selectivity control. Compound 5c proved the most potent AChE inhibitor (IC 50 = 1.44 ± 0.33 μM; SI = 16.77), while 5h exhibited preferential BuChE inhibition (IC 50 = 11.40 ± 1.25 μM). Enzyme kinetic studies confirmed a mixed‐type inhibition mechanism for both lead compounds, suggesting dual‐site engagement within the cholinesterase gorge. In the antiproliferative assay, 5e and 5c surpassed the reference drug methotrexate (IC 50 = 4.42 ± 0.15 μM) with IC 50 values of 3.57 ± 0.11 μM and 3.89 ± 0.20 μM, respectively, alongside favorable selectivity over healthy fibroblasts. In silico ADMET profiling confirmed drug‐likeness for all derivatives, and DFT calculations at the B3LYP/6‐311++G(d,p) level provided electronic rationale for observed reactivity trends. Molecular docking against human AChE (PDB: 4EY7) and BuChE (PDB: 4BDS) rationalized key stabilizing interactions including π–π stacking with Trp86/Trp286 and hydrogen bonding with active‐site residues. Collectively, these findings identify the methoxyphenol–triazole scaffold as a promising lead platform warranting further optimization for multitarget therapeutic applications in neurodegenerative and oncological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Sciences, Kahramanmaraş Sütçü İmam University, Kahramanmaras, Turkey.
- Department of Chemical Engineering, Faculty of Engineering, Kyrgyz-Turkish Manas University, Bishkek, Kyrgyz Republic.
ORCID-Profile: Sultan Onur, Mustafa Çeşme, Ferhan Tümer
Förderung
- Kahramanmaraş Sütçü İmam University
Zitieren
APA
Onur, S., Çeşme, M., & Tümer, F. (2026). Biological and In Silico Evaluation of Novel Methoxyphenol–1,2,3‐Triazole Hybrids as Multifunctional Anti‐Alzheimer's and Anticancer Agents. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70343
Vancouver
Onur S, Çeşme M, Tümer F. Biological and In Silico Evaluation of Novel Methoxyphenol–1,2,3‐Triazole Hybrids as Multifunctional Anti‐Alzheimer's and Anticancer Agents. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70343
BibTeX
@article{Onur2026,
author = {Onur, Sultan and Çeşme, Mustafa and Tümer, Ferhan},
title = {Biological and In Silico Evaluation of Novel Methoxyphenol–1,2,3‐Triazole Hybrids as Multifunctional Anti‐Alzheimer's and Anticancer Agents},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70343}
}
EUVIMED